Do Lymphatic Drainage Supplements Work? What the Evidence Actually Says

Published by Lymphatic Health Co., the company behind Lympha.

Some ingredients do have human evidence for specific outcomes, including less leg swelling and heaviness. Most of that research comes from people with venous disease, with some studies examining everyday situations such as prolonged sitting. The useful answer depends on what was taken, at what daily amount, and what the researchers measured.

If you have searched for a supplement for heavy legs or puffiness, you have probably seen promises of “lymphatic drainage” or a “lymph detox.” Those phrases tell you very little about the formula. A product can list familiar herbs without explaining their amounts or connecting them to a single human study.

There is a more useful way to evaluate a supplement: look at its ingredients, the preparations studied, and the reasoning behind the formula. That is how we approached Lympha, and it is what this article will help you assess.

Why circulation research matters to lymphatic health

Your lymphatic system collects fluid and proteins from the tissues and returns them to the bloodstream. It works alongside the blood vessels that deliver blood to tissues and carry it away.

The pressure within those vessels and the properties of their walls influence how much fluid moves into the surrounding tissue. Lymphatic transport helps clear that fluid. This is why research on veins, capillary filtration, and small-vessel circulation is relevant to tissue-fluid balance. Read the National Cancer Institute’s explanation of lymphatic anatomy and fluid balance.

That makes circulation research relevant to lymphatic health. A study measuring less leg swelling can tell us something useful about fluid accumulation, even when it does not directly measure lymphatic flow. Those are different outcomes, and we describe them accordingly.

This is the starting point for Lympha: consider the connected processes that influence tissue-fluid balance, then choose ingredients with relevant human research.

What the human studies actually show

Much of the research concerns specific preparations studied in people with chronic venous insufficiency or other forms of chronic venous disease, where blood return through the leg veins is impaired. Some studies examine more everyday conditions, such as prolonged sitting in otherwise healthy adults.

Diosmin and hesperidin: an established body of venous research

Diosmin and hesperidin are flavonoids associated with a substantial clinical literature, particularly research on micronized purified flavonoid fraction, or MPFF. Micronization reduces particle size; the composition and manufacturing characteristics of the preparation also matter.

A 2023 review combined eight studies involving 1,635 people with chronic venous disease who received MPFF at 1,000 mg daily. Average ankle circumference fell by approximately 6 mm after two months, with reductions also reported in calf circumference and the feeling of swelling. These findings included objective measurements as well as symptoms. Read the MPFF review.

The circumference figures describe changes from participants’ starting measurements, not an additional 6 mm benefit over placebo. The review pooled different study designs, only one included trial was placebo-controlled, and results varied substantially between studies.

That review sits within a broader clinical record. The six-month RELIEF study followed more than 5,000 people with symptomatic venous disease and reported improvements in symptoms and quality of life during MPFF use. It had no placebo group, so it adds information about use over time rather than establishing the treatment’s effect on its own. Read the RELIEF study.

The depth of this clinical record is why diosmin and hesperidin form the foundation of our formulation.

Grape seed extract: measured swelling during prolonged sitting

One grape seed study addressed a familiar situation: healthy women sitting for six hours.

In a double-blind, placebo-controlled crossover study, a proanthocyanidin-rich grape seed extract reduced the increase in leg volume and related fluid measurements during prolonged sitting. The research included both single-intake and 14-day intake trials. Read the grape seed sitting study.

This study is especially relevant to the everyday reasons people seek a supplement. It examined healthy participants under a familiar physical strain, and measured the fluid accumulation itself.

There is also research in clinical populations. The VICTORY randomized trial, published in a January 2026 journal issue, studied 176 people with varicose veins. A specific grape seed extract at 150 mg twice daily, alongside lifestyle measures, improved venous reflux time compared with lifestyle measures alone over 12 weeks. The study was open-label, so participants and clinicians knew which treatment was given. Read the VICTORY trial.

Together, these studies give grape seed extract a clear place in our approach: research on fluid accumulation during sitting, alongside research on venous function.

Gotu kola: research on the small vessels where fluid exchange occurs

Gotu kola, or Centella asiatica, has been studied using defined triterpenic fractions, often called TECA or TTFCA. These preparations concentrate particular plant compounds.

A placebo-controlled, dose-ranging trial in people with venous hypertension tested a triterpenic fraction at 90 and 180 mg daily for four weeks. It reported reductions in capillary filtration and improvements in ankle measures, with greater effects at the higher dose. Read the Centella capillary-filtration trial.

A systematic review of eight trials also reported improvements in several microcirculatory measurements, including the rate of ankle swelling. However, inadequate reporting left uncertainty about the risk of bias in much of the research. Read the Centella systematic review.

Centella brings another part of the picture into focus: the small vessels where fluid exchange occurs. That is the reason for its inclusion in Lympha, and for paying attention to its triterpene content.

Butcher’s broom: human evidence for leg volume and heaviness

Butcher’s broom, or Ruscus aculeatus, has a history of traditional use, but there is human trial evidence to examine as well.

In a 12-week randomized, double-blind, placebo-controlled trial in women with chronic venous insufficiency, a specific Ruscus preparation improved leg volume and symptoms including heaviness and tension. Read the standalone Ruscus trial.

A separate meta-analysis of 10 trials involving 719 patients reported benefits for several venous symptoms and objective swelling measurements. That review concerned the Ruscus, hesperidin methyl chalcone, and vitamin C combination associated with Cyclo 3 Fort. Hesperidin methyl chalcone is a distinct derivative of hesperidin, and the combination’s findings cannot be assigned to Ruscus alone. Read the combination review.

The standalone trial is particularly useful for understanding why we included butcher’s broom. It connects a specific preparation with both measured leg-volume changes and symptoms people can feel.

How strong is the evidence overall?

The findings above are worth taking seriously, while recognizing that their strength varies. A 2020 Cochrane review of oral phlebotonics, a broad group of preparations used for venous insufficiency, found that they probably reduced lower-leg swelling slightly compared with placebo. Overall, they probably made little or no difference to quality of life; adverse effects were somewhat more common, particularly digestive complaints. The available studies did not establish medium- or long-term safety. Read the Cochrane review.

The overall picture is meaningful but specific. Measured benefits exist, their size can be modest, and the evidence is stronger for some preparations and outcomes than others. That is why the details behind an ingredient matter more than the number of herbs on a label.

How to tell whether a supplement reflects the research

A label is more useful when it lets you check the connection between an ingredient and the evidence cited for it. Start with four questions.

1. How much of each active will I take daily? Look for individual amounts per full daily serving. A proprietary blend’s total weight cannot show how much of each ingredient it contains or how those amounts compare with a study.
2. What preparation is in the bottle? Look for the plant part, extract type, and specified levels of relevant compounds. Whole-herb powder, a concentrated extract, and a defined fraction can differ substantially. Standardization provides useful information, but is not proof of effectiveness.
3. Who was studied, and what improved? Research on leg volume during sitting answers a different question from research on diagnosed lymphedema. A company should connect its claims to the people and outcomes actually studied.
4. Was this finished formula tested? Ingredient research can inform a formulation. A trial of the finished product is needed to establish results for that particular combination. Look for a direct answer about which evidence the company has.

These questions help you make a comparison that a phrase such as “lymph detox” cannot provide. They also reflect the NIH’s reminder that products sold to consumers may differ from those tested in research. Read NCCIH’s supplement guidance.

Why we formulated Lympha this way

We built Lympha around human research on connected aspects of circulation and tissue-fluid balance. Diosmin and hesperidin provide the venous-research foundation. Grape seed extract adds studies of fluid accumulation during sitting and venous function. Gotu kola brings research on capillary filtration and microcirculation, while butcher’s broom adds standalone evidence on leg volume and heaviness.

Each active has a specific reason for being included, and each amount is disclosed per full daily serving:

• Micronized diosmin: 450 mg
• Hesperidin: 50 mg
• Grape seed extract: 200 mg
• Gotu kola extract: 225 mg
• Butcher’s broom extract: 150 mg

We also publish the extract specifications. Our grape seed extract is standardized to at least 95% OPCs. Our gotu kola extract contains 40% total triterpenes, providing approximately 90 mg per daily serving. Butcher’s broom is a 10:1 extract. These details let you examine what the formula contains, beyond the botanical names.

The comparison with research should be just as clear. Lympha supplies 500 mg daily of diosmin and hesperidin in a 9:1 ratio; the MPFF review above evaluated 1,000 mg daily. Our gotu kola’s total triterpene amount does not make it interchangeable with the defined TECA or TTFCA fractions used in trials. A 10:1 butcher’s broom ratio describes concentration, rather than a specified ruscogenin dose. These are relevant differences when comparing the label with a study.

Lympha’s finished formula has not been clinically tested, so ingredient studies do not establish its clinical results or prove that the combination has additive benefits. Our confidence in the formulation rests on the research informing each choice, the disclosed amounts, and the specifications we make available for scrutiny.

That is the practical difference we want you to be able to see. You can identify every active, check its daily amount, understand why we included it, and follow the research behind the decision. A proprietary blend that gives only a total weight cannot offer that same ingredient-by-ingredient comparison.

What about detox claims and quick results?

A promise to “flush toxins” should come with an explanation of which substances are being removed and how that was measured. The studies discussed here measured outcomes such as limb volume, ankle circumference, symptoms, and venous reflux. They do not demonstrate a general detoxifying effect.

More frequent urination is not evidence that lymphatic transport improved, either. For fluid-balance research to be useful, the outcome has to be defined.

There is no single established timetable for lymphatic drainage supplements as a category. The studies above range from a six-hour sitting experiment to trials lasting weeks or months. Those schedules describe the preparations tested; they cannot promise when another product will work for an individual.

What if you have lymphedema or unexplained swelling?

Diagnosed lymphedema requires a different discussion from occasional heavy legs. A small 1996 controlled trial in 57 people with arm lymphedema after breast cancer treatment reported improved swelling with a specific Ruscus-containing combination. Both groups also received manual lymphatic drainage. It is an interesting adjunctive-care finding, not evidence that Lympha treats lymphedema or replaces therapy. Read the CYCLO 3 FORT trial.

Lymphedema care can include compression, exercise, skin care, and manual lymphatic drainage within an individualized plan. Discuss supplements with your treating clinician. Read the National Cancer Institute’s treatment overview.

Swelling can also have other causes, including medication effects and heart, kidney, or venous problems. New, persistent, or worsening swelling deserves assessment. Seek urgent medical help for unexplained swelling in one leg, especially if sudden, painful, red, or warm. Swelling with chest pain or shortness of breath requires emergency care. Read NHS guidance on swelling.

Before starting a supplement, ask a clinician or pharmacist to review its ingredients if you take medication, have a medical condition, are pregnant or breastfeeding, or have surgery planned. Follow the label, and stop taking the product and seek medical advice if side effects develop. Read NCCIH’s safety guidance.

Regular movement and breaks from prolonged sitting remain sensible everyday habits. A supplement should not delay finding the cause of persistent swelling.

What makes a formula worth considering?

The words “lymphatic drainage” on a bottle are not enough to judge a supplement. The stronger case comes from relevant human studies, a clearly described formula, and an explanation of how the two connect.

We built Lympha on four areas of human ingredient research, with five disclosed actives and a specific reason for each one. The evidence library shows the studies, the daily amounts, and where our formula differs from the preparations tested. Every ingredient has a stated purpose, and you can trace each choice back to the research that informed it.

Explore the research behind Lympha.

---

This article provides general education and does not replace individual medical advice. Lympha is not intended to diagnose, treat, cure, or prevent any disease.